The exome, i.e. the protein-coding region of the genome, represents less than 1.5% of the genetic code, but contains ~85% of known disease-related variants. Exome-seq is a cost-effective alternative to whole-genome sequencing applied across a wide range of applications, including population genetics, genetic disease and cancer studies.
Examine virtually all protein-coding regions in the genome in a single test and capture the majority of the information related to genetic disease.
Assess all clinically relevant genes in a single test. Eliminate the need for multiple costly single-gene sequencing tests and significantly improve the likelihood of identifying disease-causing and high-risk variants.
Converge time, expenses and data analysis on specific areas that are most likely to be involved in the phenotype under study.
Our continuous commitment to follow and test the latest protocols and tools, as well as to develop new ones, assures the implementation of the state-of-the-art procedures and the optimization of the experimental design.
RNA-seq has now displaced microarrays as the preferred method for gene expression profiling.